Bioceres Crop Solutions CORP. (BIOX) — SEC Filings

Overview

Bioceres Crop Solutions CORP. (BIOX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 31, 2025: Bioceres Crop Solutions Corp. filed a Form 6-K on December 31, 2025, reporting for the month of December 2025. The filing indicates the company is a foreign private issuer and will file its annual reports under Form 20-F. The principal executive offices are located in Rosario, Santa Fe, Argentina.

Sentiment Summary

Across 39 filings, the sentiment breakdown is: 7 bullish, 1 bearish, 31 neutral. The dominant filing sentiment for Bioceres Crop Solutions CORP. is neutral.

Filing Type Overview

Bioceres Crop Solutions CORP. (BIOX) has filed 33 6-K, 2 20-F, 1 SC 13G, 2 SC 13D/A, 1 SC 13G/A with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (39)

• Bioceres Crop Solutions Files December 2025 6-K Report — 6-K · Dec 31, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on December 31, 2025, reporting for the month of December 2025. The filing indicates the company is a foreign pri
• Bioceres Crop Solutions Files Routine 6-K Report — 6-K · Dec 22, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on December 22, 2025, reporting its status as a foreign private issuer. The filing indicates that the company wil
• 6-K Filing — 6-K · Nov 26, 2025
• 6-K Filing — 6-K · Nov 13, 2025
• Bioceres Crop Solutions Files 6-K — 6-K · Nov 12, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on November 12, 2025, reporting as a foreign private issuer. The filing provides information regarding the compan
• Bioceres Faces Going Concern Doubts, Pivots HB4 Strategy — 20-F · Nov 10, 2025 Risk: high
  Bioceres Crop Solutions Corp. (BIOX) filed its 20-F for the fiscal year ended June 30, 2025, indicating a critical need for additional capital to continue as a
• Bioceres Crop Solutions Files 6-K Report — 6-K · Nov 6, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on November 6, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its re
• Bioceres Crop Solutions Files Routine 6-K Report — 6-K · Oct 10, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on October 10, 2025, reporting for the month of October 2025. The company, based in Rosario, Argentina, is a fore
• Bioceres Crop Solutions Files October 2025 6-K Report — 6-K · Oct 2, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on October 2, 2025, reporting for the month of October 2025. The filing is a report of a foreign private issuer a
• Bioceres Crop Solutions Reports FY25 Results — 6-K · Sep 9, 2025 Risk: low
  Bioceres Crop Solutions Corp. announced its fourth fiscal quarter and full fiscal year 2025 financial and operational results on September 9, 2025. The company,
• Bioceres Crop Solutions Files Routine 6-K Report — 6-K · Sep 2, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on September 2, 2025, reporting its status as a foreign private issuer. The company, headquartered in Rosario, Ar
• Bioceres Crop Solutions Files Routine 6-K Report — 6-K · Aug 21, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on August 21, 2025, reporting for the month of August 2025. The company, based in Rosario, Argentina, is a foreig
• Bioceres Crop Solutions Amends Convertible Note Agreements — 6-K · Jun 20, 2025 Risk: medium
  Bioceres Crop Solutions Corp. announced on June 18, 2025, amendments to its note purchase agreements for secured guaranteed convertible notes originally issued
• Bioceres Crop Solutions Files 6-K for Q1 2025 — 6-K · Jun 20, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a 6-K report for the period ending March 31, 2025. The filing includes financial information and details related to its subs
• Bioceres Crop Solutions Reports Q3 2025 Results — 6-K · May 21, 2025 Risk: low
  Bioceres Crop Solutions Corp. reported its fiscal third quarter 2025 financial and operational results on May 21, 2025. The company is a foreign private issuer
• Bioceres Crop Solutions' Rinotec Platform Gets EPA Registration — 6-K · Mar 11, 2025 Risk: medium
  Bioceres Crop Solutions Corp. announced on March 11, 2025, the EPA registration of its Rinotec insecticide and nematicide platform. This registration allows for
• Bioceres Secures US Patent for HB4 Wheat Until 2042 — 6-K · Mar 6, 2025 Risk: medium
  Bioceres Crop Solutions Corp. announced on March 5, 2025, that it has secured patent protection for its HB4 Wheat in the United States, valid until 2042. This p
• Bioceres Crop Solutions Files 6-K for Q2 2025 — 6-K · Feb 28, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a 6-K report for the period ending December 31, 2024. The filing includes financial information and details related to its s
• Bioceres Crop Solutions Reports Q2 FY2025 Results — 6-K · Feb 12, 2025 Risk: low
  Bioceres Crop Solutions Corp. announced its financial and operational results for the second fiscal quarter of 2025 on February 12, 2025. The company is a forei
• Bioceres Crop Solutions Updates Q2 2025 Expectations — 6-K · Feb 6, 2025 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on February 6, 2025, to update its expectations for the second fiscal quarter of 2025. The filing includes a pres
• Bioceres Subsidiary Raises $25.9M in Bond Offering — 6-K · Dec 2, 2024 Risk: low
  Bioceres Crop Solutions Corp. announced that its subsidiary, Rizobacter Argentina S.A., successfully completed an offering of Series X Corporate Bonds, raising
• Bioceres Crop Solutions Files 6-K with Subsidiary Financials — 6-K · Nov 27, 2024 Risk: medium
  Bioceres Crop Solutions Corp. filed a 6-K report for the period ending September 30, 2024. The filing includes information on its parent companies, related part
• Bioceres Crop Solutions Reports Q1 FY25 Results — 6-K · Nov 12, 2024 Risk: low
  Bioceres Crop Solutions Corp. reported its first fiscal quarter 2025 financial and operational results on November 12, 2024. The company is a foreign private is
• Bioceres Crop Solutions Files 2024 Annual 20-F Report — 20-F · Oct 30, 2024 Risk: medium
  Bioceres Crop Solutions Corp. filed its annual 20-F report for the fiscal year ending June 30, 2024. The filing details the company's financial performance and
• SC 13G Filing — SC 13G · Oct 23, 2024
• Bioceres Crop Solutions Files 2024 AGM Proxy Materials — 6-K · Oct 3, 2024 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on October 3, 2024, to provide notice and proxy materials for its 2024 Annual General Meeting. The filing include
• Bioceres Crop Solutions Files 6-K with Financial Statements — 6-K · Sep 30, 2024 Risk: low
  Bioceres Crop Solutions Corp. filed a Form 6-K on September 30, 2024, to report its consolidated financial statements for the years ended June 30, 2024, 2023, a
• Bioceres Group PLC Amends 13D Filing — SC 13D/A · Sep 20, 2024 Risk: medium
  Bioceres Group PLC, through Bioceres LLC, has filed an amendment (No. 10) to its Schedule 13D concerning Bioceres Crop Solutions Corp. The filing, dated Septemb
• Bioceres Crop Solutions Reports FY24 Results — 6-K · Sep 10, 2024 Risk: low
  Bioceres Crop Solutions Corp. announced its financial and operational results for the fourth fiscal quarter and full fiscal year 2024 on September 10, 2024. The
• Bioceres Gets US Green Light for Drought-Tolerant Wheat — 6-K · Aug 28, 2024 Risk: medium
  Bioceres Crop Solutions Corp. announced on August 28, 2024, that it has received approval for the cultivation of its drought-tolerant HB4 wheat in the United St
• Bioceres Subsidiary Raises $20M in Bond Offering — 6-K · Jul 1, 2024 Risk: medium
  Bioceres Crop Solutions Corp. announced on July 1, 2024, that its subsidiary, Rizobacter Argentina S.A., successfully completed an offering of Series IX Corpora
• Bioceres Crop Solutions Files 6-K for Q3 2024 — 6-K · May 29, 2024 Risk: low
  Bioceres Crop Solutions Corp. filed a 6-K report for the period ending March 31, 2024. The filing includes financial information and details related to its subs
• Bioceres Crop Solutions Reports Q3 2024 Results — 6-K · May 14, 2024 Risk: low
  Bioceres Crop Solutions Corp. reported its fiscal third quarter 2024 financial and operating results on May 14, 2024. The company is based in Rosario, Argentina
• Bioceres Crop Solutions' Prodigy Bio-Insecticide Approved in Brazil — 6-K · May 7, 2024 Risk: medium
  Bioceres Crop Solutions Corp. announced on May 7, 2024, that Brazil's National Biosafety Technical Commission (CTNBio) has approved its new generation bio-insec
• Bioceres Group PLC Files 13D/A Amendment — SC 13D/A · Mar 25, 2024 Risk: low
  Bioceres Group PLC, through Bioceres LLC, filed an amendment (No. 9) to its Schedule 13D on March 25, 2024, regarding Bioceres Crop Solutions Corp. The filing i
• Bioceres Files 6-K, Details H1 2024 Financials & Related Party Deals — 6-K · Feb 28, 2024 Risk: medium
  Bioceres Crop Solutions Corp. filed a 6-K on February 28, 2024, for the period ending December 31, 2023. The filing details financial information and related pa
• SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Bioceres Q2 Revenue Jumps 49% to $140.2M, Net Income $1.2M — 6-K · Feb 9, 2024 Risk: low
  Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported strong fiscal second quarter 2024 financial results on February 8, 2024, with revenues soaring to $140.2 m
• Bioceres Crop Solutions Releases FY23 Scope 1 & 2 GHG Emissions Report — 6-K · Jan 24, 2024
  Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced on January 23, 2024, the release of its global greenhouse gas emissions report for fiscal year 2023, deta

Risk Profile

Risk Assessment: Of BIOX's 34 recent filings, 1 were flagged as high-risk, 10 as medium-risk, and 23 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

• Maria Paula Savanti
• Matthew S. Poulter, Esq.
• Emilio Minvielle, Esq.
• Gloria Montaron Estrada
• Matthew S. Poulter
• Federico Trucco

Industry Context

Bioceres operates in the competitive crop productivity products market, which demands continuous technological advancement. The industry is influenced by trends in agricultural production, consolidation, and market opportunities. Regulatory approvals are a critical gating factor for new product commercialization, and global economic conditions, including trade barriers and conflicts, add layers of complexity.

Top Tags

sec-filing (12) · foreign-private-issuer (9) · financial-results (7) · agriculture (5) · 6-K (4) · 6-k (3) · financial-update (3) · subsidiaries (3) · regulatory-approval (3) · biotechnology (3)

Key Numbers

• Ordinary shares issued and outstanding: 63,228,239 — As of June 30, 2025, indicating current share count.
• Par value per ordinary share: $0.0001 — The nominal value of each ordinary share.
• Convertible Notes Principal: $55 million — Aggregate principal amount of secured guaranteed convertible notes affected by the amendments.
• Reporting Period End Date: 20250331 — Indicates the end of the financial period covered by the report.
• Filing Date: 20250620 — The date the report was officially submitted to the SEC.
• Patent Expiration: 2042 — US patent protection for HB4 Wheat
• Bond Offering Proceeds: $25.9M — Amount raised by subsidiary Rizobacter Argentina S.A.
• Prior Year Period End Date: 2023-09-30 — Used for comparative financial analysis against the current reporting period.
• Fiscal Year End: 06-30 — Indicates the end of the reporting period for the 20-F filing.
• Reporting Period End: 2024-06-30 — Specific date for which financial information is reported.
• Accession Number: 0001104659-24-101793 — Unique identifier for the SEC filing
• Period End Date: 2024-03-31 — The report covers financial data up to this date.
• Previous Fiscal Year End: 2023-06-30 — Used for comparative financial reporting.
• Amendment Number: 9 — Indicates this is the ninth amendment to the original filing.
• 2Q24 Revenues: $140.2 million — Represents a 49% year-over-year increase, showing significant top-line growth.

Forward-Looking Statements

• {"claim":"Bioceres Crop Solutions Corp. will likely see continued investor interest due to strong revenue growth.","entity":"Bioceres Crop Solutions Corp.","targetDate":"next 6-12 months","confidence":"high"}
• {"claim":"The company's focus on 'regenerate agricultural ecosystems' and 'resilient to climate change' solutions will continue to drive sales.","entity":"Bioceres Crop Solutions Corp.","targetDate":"next 12-24 months","confidence":"medium"}

Frequently Asked Questions